ArticleMedicine2026
Nationwide age-adjusted trends and inequities in vascular intestinal disorder mortality in the United States, 1999 to 2023.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular intestinal disorders (VID), including acute mesenteric ischemia and related intestinal vascular insufficiency syndromes, are rare but highly lethal causes of abdominal emergency mortality. National trends in VID mortality, and whether improvements have been equitable across demographic and geographic groups, have not been characterized through 2023. We conducted a nationwide ecological analysis of VID mortality in the United States from 1999 to 2023 using the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research. We included adults aged 25 years or older when VID was listed as the underlying cause of death. For each year, we extracted the national death count and the age-adjusted mortality rate (per 1,00,000 population) and evaluated temporal change. From 1999 to 2023, 2,03,870 VID deaths occurred. Annual deaths declined from 8711 in 1999 to 7676 in 2023. Over the same period, the national age-adjusted mortality rate decreased from 4.93 to 2.75/1,00,000, corresponding to an average annual percent change of -2.41%. Deaths were concentrated in older adults: individuals aged 75 to 84 years accounted for 66,509 deaths (32.6% of all VID deaths), and those aged 85 years or older accounted for 59,009 deaths (28.9%). Females accounted for 1,30,125 cumulative VID deaths and males for 73,745. Nonmetropolitan counties and Southern regions carried a disproportionate share of deaths. Although VID mortality declined on an age adjusted basis, the absolute burden remains greatest in the oldest adults and in structurally disadvantaged settings, indicating persistent geographic and demographic inequity during and beyond the COVID-19 era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.